Standard BioTools Inc.LABNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank97
3Y CAGR+59.3%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+59.3%/yr
Quarterly compound
Percentile
P97
Near historical high
vs 3Y Ago
4x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 92.75% |
| Q3 2025 | -2.36% |
| Q2 2025 | 36.17% |
| Q1 2025 | -102.61% |
| Q4 2024 | 42.10% |
| Q3 2024 | 26.50% |
| Q2 2024 | 35.21% |
| Q1 2024 | -347.39% |
| Q4 2023 | -14.79% |
| Q3 2023 | -21.15% |
| Q2 2023 | -7.08% |
| Q1 2023 | 52.37% |
| Q4 2022 | 22.95% |
| Q3 2022 | 16.33% |
| Q2 2022 | -87.91% |
| Q1 2022 | -120.47% |
| Q4 2021 | 33.35% |
| Q3 2021 | 40.54% |
| Q2 2021 | 4.98% |
| Q1 2021 | -37.29% |
| Q4 2020 | -192.43% |
| Q3 2020 | -43.92% |
| Q2 2020 | 35.57% |
| Q1 2020 | 11.53% |
| Q4 2019 | -2.12% |
| Q3 2019 | -8.51% |
| Q2 2019 | 73.37% |
| Q1 2019 | -2999.70% |
| Q4 2018 | 84.56% |
| Q3 2018 | 3.14% |
| Q2 2018 | 72.93% |
| Q1 2018 | -3853.58% |
| Q4 2017 | 105.07% |
| Q3 2017 | -1.22% |
| Q2 2017 | 8.15% |
| Q1 2017 | 19.58% |
| Q4 2016 | 23.59% |
| Q3 2016 | -68.39% |
| Q2 2016 | 0.72% |
| Q1 2016 | 27.37% |